Last updated on November 2019

Study of GEN-1 With NACT for Treatment of Ovarian Cancer (OVATION 2)

Brief description of study

This is a randomized, open label, multicenter trial to evaluate the safety, dosing, efficacy and biological activity of intraperitoneal GEN-1 plus NACT compared to NACT alone.

Clinical Study Identifier: NCT03393884

Find a site near you

Start Over

Women & Infants Hopsital of Rhode Island

Providence, RI United States
  Connect »